Cardiac Science Acquisition Approved
A Times Staff Writer
Defibrillator maker Cardiac Science Inc. said this week that shareholders have approved the Irvine company’s acquisition of Survivalink Corp., a Minneapolis maker of external defibrillators, for $71 million in cash and stock.
Shareholders also approved an increase in the number of authorized shares to a maximum of 100 million from 40 million, Cardiac said.
